Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Despina D. Briana, Kleopatra Germanou, Maria Boutsikou, Theodora Boutsikou, Nikolaos Athanasopoulos, Antonios Marmarinos, Dimitrios Gourgiotis & Ariadne Malamitsi-Puchner. (2018) Potential prognostic biomarkers of cardiovascular disease in fetal macrosomia: the impact of gestational diabetes. The Journal of Maternal-Fetal & Neonatal Medicine 31:7, pages 895-900.
Read now
Read now
Dorte Glintborg, Louise L. Christensen, Thue Kvorning, Rasmus Larsen, Kurt Højlund, Kim Brixen, David M. Hougaard, Aase Handberg & Marianne Andersen. (2015) Differential effects of strength training and testosterone treatment on soluble CD36 in aging men: Possible relation to changes in body composition. Scandinavian Journal of Clinical and Laboratory Investigation 75:8, pages 659-666.
Read now
Read now
Andrzej Krzystolik, Violetta Dziedziejko, Krzysztof Safranow, Grzegorz Kurzawski, Michał Rać, Dagmara Sagasz-Tysiewicz, Wojciech Poncyljusz, Katarzyna Jakubowska, Dariusz Chlubek & Monika E. Rać. (2015) Is plasma soluble CD36 associated with cardiovascular risk factors in early onset coronary artery disease patients?. Scandinavian Journal of Clinical and Laboratory Investigation 75:5, pages 398-406.
Read now
Read now
Articles from other publishers (31)
Yun Li, Yaxi Chen & Xiong Z. Ruan. (2023) The association of soluble cluster of differentiation 36 with metabolic diseases: A potential biomarker and therapeutic target. Pediatric Discovery 1:1.
Crossref
Crossref
Arnulfo Ramos-Jiménez, Ruth A. Zavala-Lira, Verónica Moreno-Brito & Everardo González-Rodríguez. (2022) FAT/CD36 Participation in Human Skeletal Muscle Lipid Metabolism: A Systematic Review. Journal of Clinical Medicine 12:1, pages 318.
Crossref
Crossref
Hua Wang, Wei-hong Yan, Lei Gong, Nian-peng Song, Chun-xiao Wang & Lin Zhong. (2022) Platelet CD36 links overweight and a prothrombotic phenotype in patients with non-valvular atrial fibrillation. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Maïmouna Touré, Abdoulaye Samb, Mbaye Sène, Souleymane Thiam, Cheikh A. B. Mané, Abdou K. Sow, Awa Ba-Diop, Modou O. Kane, Mamadou Sarr, Abdoulaye Ba & Lamine Gueye. (2022) Impact of the interaction between the polymorphisms and hypermethylation of the CD36 gene on a new biomarker of type 2 diabetes mellitus: circulating soluble CD36 (sCD36) in Senegalese females. BMC Medical Genomics 15:1.
Crossref
Crossref
Yiliang Chen, Jue Zhang, Weiguo Cui & Roy L. Silverstein. (2022) CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate. Journal of Experimental Medicine 219:6.
Crossref
Crossref
Anna Bobrus-Chociej, Natalia Wasilewska, Ewa Harasim-Symbor, Marta Flisiak-Jackiewicz, Małgorzata Wojtkowska, Adrian Chabowski & Dariusz Lebensztejn. (2021) Lack of change in serum sCD36 concentration in children with non-alcoholic fatty liver disease – A preliminary study. Advances in Medical Sciences 66:1, pages 35-40.
Crossref
Crossref
Ayon Bhattacharya, Rani Ashouri, Madison Fangman, Alexandra Mazur, Timothy Garett & Sylvain Doré. (2021) Soluble Receptors Affecting Stroke Outcomes: Potential Biomarkers and Therapeutic Tools. International Journal of Molecular Sciences 22:3, pages 1108.
Crossref
Crossref
Ana-Maria Dobri, Maria Dudău, Ana-Maria Enciu & Mihail Eugen Hinescu. (2021) CD36 in Alzheimer’s Disease: An Overview of Molecular Mechanisms and Therapeutic Targeting. Neuroscience 453, pages 301-311.
Crossref
Crossref
Patricia Rada, Águeda González-Rodríguez, Carmelo García-Monzón & Ángela M. Valverde. (2020) Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?. Cell Death & Disease 11:9.
Crossref
Crossref
Kamila Puchałowicz & Monika Ewa Rać. (2020) The Multifunctionality of CD36 in Diabetes Mellitus and Its Complications—Update in Pathogenesis, Treatment and Monitoring. Cells 9:8, pages 1877.
Crossref
Crossref
Ping Yang, Han Zeng, Wei Tan, Xiaoqing Luo, Enze Zheng, Lei Zhao, Li Wei, Xiong Z. Ruan, Yao Chen & Yaxi Chen. (2020) Loss of CD36 impairs hepatic insulin signaling by enhancing the interaction of PTP1B with IR. The FASEB Journal 34:4, pages 5658-5672.
Crossref
Crossref
Jun Sung Moon, Udayakumar Karunakaran, Elumalai SumaSeung Min ChungKyu Chang Won. (2020) The Role of CD36 in Type 2 Diabetes Mellitus: β-Cell Dysfunction and Beyond. Diabetes & Metabolism Journal 44:2, pages 222.
Crossref
Crossref
Yeli Wang, Jingwen Zhu, Sarah AronerKim OvervadTianxi CaiMing YangAnne TjønnelandAase HandbergMajken K. Jensen. (2020) Plasma CD36 and Incident Diabetes: A Case-Cohort Study in Danish Men and Women. Diabetes & Metabolism Journal 44:1, pages 134.
Crossref
Crossref
Daniella van de Langenberg, Jelle J. Vlaanderen, Martijn E. T. Dolle, Aase Handberg, Roel C. H. Vermeulen & Linda W. M. van Kerkhof. (2019) Plasma sCD36 as non-circadian marker of chronic circadian disturbance in shift workers. PLOS ONE 14:10, pages e0223522.
Crossref
Crossref
Yeli Wang, Manja Koch, Romina di Giuseppe, Kirsten Evans, Jan Borggrefe, Ute Nöthlings, Aase Handberg, Majken K Jensen & Wolfgang Lieb. (2019) Associations of Plasma CD36 and Body Fat Distribution. The Journal of Clinical Endocrinology & Metabolism 104:9, pages 4016-4023.
Crossref
Crossref
Dongxiao Ding, Guozhu Ye, Yi Lin, Yanyang Lu, Han Zhang, Xu Zhang, Zhenyu Hong, Qiansheng Huang, Yulang Chi, Jinsheng Chen & Sijun Dong. (2019) MicroRNA-26a-CD36 signaling pathway: Pivotal role in lipid accumulation in hepatocytes induced by PM2.5 liposoluble extracts. Environmental Pollution 248, pages 269-278.
Crossref
Crossref
Francesca Santilli, Paola Simeone & Rossella Liani. 2019. Platelets. Platelets
469
503
.
Paola Simeone, Andrea Boccatonda, Rossella Liani & Francesca Santilli. (2018) Significance of urinary 11-dehydro-thromboxane B2 in age-related diseases: Focus on atherothrombosis. Ageing Research Reviews 48, pages 51-78.
Crossref
Crossref
Yeli Wang, Jingwen Zhu, Aase Handberg, Kim Overvad, Anne Tjønneland, Eric B. Rimm & Majken K. Jensen. (2018) Association between plasma CD36 levels and incident risk of coronary heart disease among Danish men and women. Atherosclerosis 277, pages 163-168.
Crossref
Crossref
M.E. Rać, K. Safranow, B. Garanty-Bogacka, V. Dziedziejko, G. Kurzawski, M. Goschorska, A. Kuligowska, N. Pauli & D. Chlubek. (2018) CD36 gene polymorphism and plasma sCD36 as the risk factor in higher cholesterolemia. Archives de Pédiatrie 25:3, pages 177-181.
Crossref
Crossref
Ewa Anna Grzegorczyk, Ewa Harasim-Symbor, Bartlomiej Lukaszuk, Dorota Harasiuk, Barbara Choromanska, Piotr Mysliwiec, Malgorzata Zendzian-Piotrowska & Adrian Chabowski. (2018) Lack of pronounced changes in the expression of fatty acid handling proteins in adipose tissue and plasma of morbidly obese humans. Nutrition & Diabetes 8:1.
Crossref
Crossref
S Heebøll, M K Poulsen, M J Ornstrup, T N Kjær, S B Pedersen, S Nielsen, H Grønbæk & A Handberg. (2016) Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls. International Journal of Obesity 41:2, pages 262-267.
Crossref
Crossref
Francesca Santilli, Paola Simeone, Rossella Liani & Giovanni Davì. 2017. Platelets in Thrombotic and Non-Thrombotic Disorders. Platelets in Thrombotic and Non-Thrombotic Disorders
1225
1238
.
L Knøsgaard, K Kazankov, N H Birkebæk, P Holland-Fischer, A Lange, J Solvig, A Hørlyck, K Kristensen, S Rittig, H Vilstrup, H Grønbæk & A Handberg. (2016) Reduced sCD36 following weight loss corresponds to improved insulin sensitivity, dyslipidemia and liver fat in obese children. European Journal of Clinical Nutrition 70:9, pages 1073-1077.
Crossref
Crossref
Francesca Santilli, Paola Simeone, Rossella Liani & Giovanni Davì. (2015) Platelets and diabetes mellitus. Prostaglandins & Other Lipid Mediators 120, pages 28-39.
Crossref
Crossref
Nassim Dali-Youcef & Romeo Ricci. 2016. Metabolic Control. Metabolic Control
195
220
.
Luz E Ramos-Arellano, José F Muñoz-Valle, Ulises De la Cruz-Mosso, Aralia B Salgado-Bernabé, Natividad Castro-Alarcón & Isela Parra-Rojas. (2014) Circulating CD36 and oxLDL levels are associated with cardiovascular risk factors in young subjects. BMC Cardiovascular Disorders 14:1.
Crossref
Crossref
L Knøsgaard, S B Thomsen, M Støckel, H Vestergaard & A Handberg. (2014) Circulating sCD36 is associated with unhealthy fat distribution and elevated circulating triglycerides in morbidly obese individuals. Nutrition & Diabetes 4:4, pages e114-e114.
Crossref
Crossref
Carmelo García-Monzón, Oreste Lo Iacono, Javier Crespo, Manuel Romero-Gómez, Javier García-Samaniego, Miguel Fernández-Bermejo, Agustín Domínguez-Díez, Javier Rodríguez de Cía, Alicia Sáez, José Luís Porrero, Javier Vargas-Castrillón, Enrique Chávez-Jiménez, Susana Soto-Fernández, Ainhoa Díaz, Rocío Gallego-Durán, Antonio Madejón & María Eugenia Miquilena-Colina. (2014) Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease. European Journal of Clinical Investigation 44:1, pages 65-73.
Crossref
Crossref
Stine Venø, Michael Nielsen, Søren Lundbye-Christensen, Erik Schmidt & Aase Handberg. (2013) The Effect of Low-Dose Marine n-3 Fatty Acids on Plasma Levels of sCD36 in Overweight Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial. Marine Drugs 11:9, pages 3324-3334.
Crossref
Crossref
Rossella Liani, Bente Halvorsen, Simona Sestili, Aase Handberg, Francesca Santilli, Natale Vazzana, Gloria Formoso, Pål Aukrust & Giovanni Davì. (2012) Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients. Free Radical Biology and Medicine 52:8, pages 1318-1324.
Crossref
Crossref